Topics in Molecular Medicine
University of Pennsylvania · PA · PHRM5420
Topics in Molecular Medicine is a subject at University of Pennsylvania, PA. It covers topics like life-sciences, medical-sciences, medicinal-chemistry, molecular-biology. It is part of 1 degree. The information below is compiled from public course material — approximate, not official.
University of Pennsylvania
PHRM5420
3.00
Topics covered
Degrees that include Topics in Molecular Medicine
Frequently asked questions
What is Topics in Molecular Medicine about?
Topics in Molecular Medicine covers topics like life-sciences, medical-sciences, medicinal-chemistry, molecular-biology.
Which degrees include Topics in Molecular Medicine?
Topics in Molecular Medicine is part of 1 degree, including Doctor of Medicine, MD.
How many credit points is Topics in Molecular Medicine?
Topics in Molecular Medicine at University of Pennsylvania is typically around 3.00 credit points. Approximate — confirm with the university.
Where is Topics in Molecular Medicine taught?
Topics in Molecular Medicine is taught at University of Pennsylvania, PA.
Studying Topics in Molecular Medicine?
Peernovo helps students research, choose and thrive at university — across Australia, the US, the UK and Canada — powered by our AI backbone:
- Explore & compare degrees — across universities and countries with honest, specific information.
- "What Can I Be?" career guidance — an AI pathway councillor that maps degrees to careers.
- See who's studying — your degree at your university — find classmates and study groups.
- AI Task Coach — a Socratic study companion that plans your work around your life.
- Honours & Thesis Research Coach — structure and move your research project forward.
- Smart study planner, exam prep and a daily digest — to keep you on track.
Sources: University of Pennsylvania public course catalogue. Information is compiled and summarised — not copied verbatim — and is approximate; always confirm with the original source.
Something not right on this page, or want it changed? Let us know and we'll review it.